CHICAGO, April 1, 2025 /PRNewswire/ — Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, today announced the close of Linden Structured Capital Fund II ...

Linden Capital Partners completed its sixth buyout fund at $5.4 billion, nearly a billion dollars over its target, in just under nine months.

Linden Capital Partners is exploring strategic options including the sale of a minority stake, according to people with knowledge of the matter. The firm is working with an adviser to solicit ...

Blue Owl Capital Inc. and Lunate Capital bought a minority stake in Linden Capital Partners, a health-care private equity firm, as part of their joint venture targeting investments in mid-sized ...

Linden Capital Partners (“Linden”), which invested in Vital Care in 2020, remains an ongoing investor in the Company alongside management and the Bell family.

Healthcare-focused private equity firm Linden Capital Partners completed its acquisition of the revenue cycle management company Aspirion Aug. 2.

Blue Owl Capital Inc.’s arm that invests in other alternative-asset managers is nearing a deal to acquire a minority stake in health-care-focused private equity firm Linden Capital Partners ...

CHICAGO and WALTHAM, Mass., March 12, 2024 /PRNewswire/ -- Linden Capital Partners ("Linden"), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced today ...

Linden Capital Partners ("Linden"), a Chicago-based healthcare private equity firm, today announced the close of Linden Structured Capital Fund II ("SCF II" or "the Fund"). The Fund closed with ...